Yevgeniy Antipin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yevgeniy Antipin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Arnold
Center for Molecular Oncology, University of Connecticut School of Medicine
1 shared publication - Andrew Uzilov
Sema4
1 shared publication Aye S. Moe
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
1 shared publication- Bin Tean Teh
Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore 169857, Singapore
1 shared publication - Branca Maria Cavaco
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG) 1
1 shared publication - Chetanya Pandya
Sema4, a Mount Sinai venture , Stamford, CT 06902, USA
1 shared publication
Latest Publications
- Open Access
- 23 March 2017
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 2 (6) , e92061
Genomic profiling reveals mutational landscape in parathyroid carcinomas
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic intervention. We generated and analyzed whole-exome sequencing data from 17 patients to identify somatic and germline genetic alterations. A panel of selected genes was sequenced in a 7-tumor expansion cohort. We show that 47% (8 of 17) of the tumors harbor somatic mutations in the CDC73 tumor suppressor, with germline inactivating variants in 4 of the 8 patients. The PI3K/AKT/mTOR pathway was altered in 21% of the 24 cases, revealing a major oncogenic pathway in PC. We observed CCND1 amplification in 29% of the 17 patients, and a previously unreported recurrent mutation in putative kinase ADCK1 . We identified the first sporadic PCs with somatic mutations in the Wnt canonical pathway, complementing previously described epigenetic mechanisms mediating Wnt activation. This is the largest genomic sequencing study of PC, and represents major progress toward a full molecular characterization of this rare malignancy to inform improved and individualized treatments.
- 23 March 2017
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 2 (6) , e92061
Open AccessGenomic profiling reveals mutational landscape in parathyroid carcinomas
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic intervention. We generated and analyzed whole-exome sequencing data from 17 patients to identify somatic and germline genetic alterations. A panel of selected genes was sequenced in a 7-tumor expansion cohort. We show that 47% (8 of 17) of the tumors harbor somatic mutations in the CDC73 tumor suppressor, with germline inactivating variants in 4 of the 8 patients. The PI3K/AKT/mTOR pathway was altered in 21% of the 24 cases, revealing a major oncogenic pathway in PC. We observed CCND1 amplification in 29% of the 17 patients, and a previously unreported recurrent mutation in putative kinase ADCK1 . We identified the first sporadic PCs with somatic mutations in the Wnt canonical pathway, complementing previously described epigenetic mechanisms mediating Wnt activation. This is the largest genomic sequencing study of PC, and represents major progress toward a full molecular characterization of this rare malignancy to inform improved and individualized treatments.
- Open Access
EVfold.org: Evolutionary Couplings and Protein 3D Structure Prediction
Recently developed maximum entropy methods infer evolutionary constraints on protein function and structure from the millions of protein sequences available in genomic databases. The EVfold web server (at EVfold.org) makes these methods available to predict functional and structural interactions in proteins. The key algorithmic development has been to disentangle direct and indirect residue-residue correlations in large multiple sequence alignments and derive direct residue-residue evolutionary couplings (EVcouplings or ECs). For proteins of unknown structure, distance constraints obtained from evolutionarily couplings between residue pairs are used to de novo predict all-atom 3D structures, often to good accuracy. Given sufficient sequence information in a protein family, this is a major advance toward solving the problem of computing the native 3D fold of proteins from sequence information alone. Availability: EVfold server at http://evfold.org/ Contact: evfoldtest@gmail.com Abbreviations: DI direct information EC evolutionary coupling EV evolutionary MSA multiple sequence alignment PLM pseudo-likelihood maximization PPV positive predictive value (number of true positives divided by the sum of true and false positives) TM-score template modeling score
Open AccessEVfold.org: Evolutionary Couplings and Protein 3D Structure Prediction
Recently developed maximum entropy methods infer evolutionary constraints on protein function and structure from the millions of protein sequences available in genomic databases. The EVfold web server (at EVfold.org) makes these methods available to predict functional and structural interactions in proteins. The key algorithmic development has been to disentangle direct and indirect residue-residue correlations in large multiple sequence alignments and derive direct residue-residue evolutionary couplings (EVcouplings or ECs). For proteins of unknown structure, distance constraints obtained from evolutionarily couplings between residue pairs are used to de novo predict all-atom 3D structures, often to good accuracy. Given sufficient sequence information in a protein family, this is a major advance toward solving the problem of computing the native 3D fold of proteins from sequence information alone. Availability: EVfold server at http://evfold.org/ Contact: evfoldtest@gmail.com Abbreviations: DI direct information EC evolutionary coupling EV evolutionary MSA multiple sequence alignment PLM pseudo-likelihood maximization PPV positive predictive value (number of true positives divided by the sum of true and false positives) TM-score template modeling score